Characterization of immune responses following intramuscular DNA immunization with the MOMP gene of Chlamydia trachomatis mouse pneumonitis strain

Immunology

Volumn 96, Issue 2, 1999, Pages 314-321

  Zhang, D J ^a   Yang, X ^a   Shen, C ^a   Brunham, R C ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; GAMMA INTERFERON; IMMUNOGLOBULIN G2A; OUTER MEMBRANE PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ANTIGEN SPECIFICITY; ARTICLE; CELLULAR IMMUNITY; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DELAYED HYPERSENSITIVITY; FEMALE; HELPER CELL; HUMORAL IMMUNITY; INTRAMUSCULAR DRUG ADMINISTRATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; VACCINATION;

ANIMALS; BACTERIAL OUTER MEMBRANE PROTEINS; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; FEMALE; HYPERSENSITIVITY, DELAYED; IMMUNOGLOBULIN G; INJECTIONS, INTRAMUSCULAR; INTERFERON TYPE II; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; PNEUMONIA; PORINS; TH1 CELLS; VACCINES, DNA;

EID: 0032927268     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1999.00682.x     Document Type: Article

References (38)

1. 1. BRUNHAM R.C. (1994) Vaccine design for the prevention of Chlamydia trachomatis infection. In: Chlamydial Infections Proceedings of the Eighth International Symposium on Human Chlamydial Infections (Chantilly, France) (eds Orfila J., Byrne G.I., Chernesky M.A. et al.), p. 73. Società Editrice Esculapio, Bologna, Ilaly.
2. 2. BRUNHAM R.C. & PEELING R.W. (1994) Chlamydia trachomatis antigens: role in immunity and pathogenesis. Infections Agents and Disease 3, 218.
3. 3. STEPHENS R.S. (1993) Challenge of Chlamydia research. Infectious Agents and Disease 1, 279.
4. 4. BRUNHAM R.C., KIMANI J., BWAYO J. et al. (1996) The epidemiology of Chlamydia trachomatis within a sexually transmitted diseases core group. J Infect Dis 173, 950.
5. 5. JAWETZ, E., ROSE L., HANNA L. & THYGESON P. (1965) Experimental inclusion conjunctivitis in man. JAMA 194, 620.
6. 6. GRAYSTON J.T. & WANG S.-P. (1978) The potential for vaccine against infection of the genital tract with Chlamydia trachomatis. Sex Trans Dis 5, 73.
7. 7. SOWA S., SOWA J., COLLIER L.H. & BLYTH W.A. (1969) Trachoma vaccine field trials in The Gambia. J Hyg Camb 67, 699.
8. 8. COLLIER L.H. (1961) Experiments with trachoma vaccines: Experimental system using inclusion blennorrhoea virus. Lancet 1, 795.
9. 9. WOOLRIDGE R.L., GRAYSTON J.T., CHANG I.H., CHENG K.H., YANG C.Y. & NEAVE C. (1967) Field trial of a monovalent and of a bivalent mineral oil adjuvant trachoma vaccine in Taiwan school children. Am J Ophthalmol 63, 1645.
10. 10. MORRISON R.P., MANNING D.S. & CALDWELL H.D. (1992) Immunology of Chlamydia trachomatis infections: Immunoprotective and immunopathogenetic responses. In: Advances in Host Defense Mechanisms: Sexually Transmitted Diseases (eds.Gallin J.I. & Fauci A.S.), Vol 8, p. 57. Raven Press, New York.
11. 11. BATTEIGER B.E., RANK R.G., BAVOIL P.M. & SODERBERG L.S.F. (1993) Partial protection against genital reinfection by immunization of guinea-pigs with isolated outer-membrane proteins of the chlamydial agent of guinea-pig inclusion conjunctivitis. J Gen Microbiol 139, 2965.
12. 12. CAMPOS M., PAL S., O'BRIEN T.P., TAYLOR H.R., PRENDERGAST R.A. & WHITTUM-HUDSON J.A. (1995) A chlamydial major outer membrane protein extract as a trachoma vaccine candidate. Invest Ophthalmol Vis Sci 36, 1477.
13. 13. JONES G.E., JONES K.A., MACHELL J., BREBNER J., ANDERSON I.E. & How S. (1995) Efficacy trials with tissue-culture grown, inactivated vaccines against chlamydial abortion in sheep. Vaccine 13, 715.
14. 14. PAL S., THEODOR I., DE PETERSON E.M. & LA MAZA L.M. (1997) Immunization with an acellular vaccine consisting of the outer membrane complex of Chlamydia trachomatis induces protection against a genital challenge. Infect Immun 65, 3361.
15. 15. TAN T.-W., HERRING A.J., ANDERSON I.E. & JONES G.E. (1990) Protection of sheep against Chlamydia psittaci infection with a subcellular vaccine containing the major outer membrane protein. Infect Immun 58, 3101.
16. 16. TAYLOR H.R., WHITTUM-HUDSON J., SCHACHTER J., CALDWELL H.D. & PRENDERGASI R.A. (1988) Oral immunization with chlamydial major outer membrane protein (MOMP). Invest Ophthalmol Vis Sci 29, 1847.
17. 17. TUFFREY M., ALEXANDER F., CONLAN W., WOODS C, & WARD M. (1992) Heterotypic protection of mice against chlamydial salpingitis and colonization of the lower genital tract with a human serovar F isolate of Chlamydia trachomatis by prior immunization with recombinant serovar L1 major outer-membrane protein. J Gen Microbiol 138, 1707.
18. 18. SU H., PARNELL M. & CALDWELL H.D. (1995) Protective efficacy of a parenterally administered MOMP-derived synthetic oligopeptide vaccine in a murine model of Chlamydia travhomatis genital tract infection: Serum neutralizing IgG antibodies do not protect against chlamydial genital tract infection. Vaccine 13, 1023.
19. 19. MURDIN A.D., SU H., KLEIN M.H. & CALDWELL H.D. (1995) Poliovirus hybrids exprressing neutralization epitopes from variable domains I and IV of the major outer membrane protein of Chlamydia trachomatis elicit broadly cross-reactive C. trachomatis-neutralizing antibodies. Infect Immun 63, 1116.
20. 20. MURDIN A.D., SU H., MANNING D.S., KLEIN M.H., PARNELL M.J. & CALDWELL H.D. (1993) A poliovirus hybrid expressing a neutralization epitope from the major outer membrane protein of Chlamydia trachomatis is highly immunogenic. Infect Immun 61, 4406.
21. 21. HAYES L.J., CONLAN J.W., EVERSON J.S., WARD M.E. & CLARKE I.N. (1991) Chlamydia trachomatis major outer membrane protein epitopes expressed as fusions with LamB in an attenuated aroA strain of Salmonella typhimurium; their application as potential immunogens. J Gen Microbiol 137, 1557.
22. 22. YANG X. & BRUNHAM R.C. (1998) T-lymphocyte immunity in host defence against Chlamydia trachomatis and its implications for vaccine development. Can J Infect Dis 9, 99.
23. 23. HOLLAND M.J., BAILEY R.L., CONWAY D.J. et al. (1996) T helper type-1 (Th1) /Th2 profiles of peripheral blood mononuclear cells (PBMC); responses to antigens of Chlamydia trachomatis in subjects with severe trachomatous scarring. Clin Exp Immunol 105, 429.
24. 24. MABEY D. & BAILEY R. (1996) Immunity to Chlamydia trachomatis: Lessons from a Gambian village. J Med Microbiol 45, 1.
25. 25. ZHANG D.-J., YANG X., BERRY J., SHEN C., MCCLARTY G. & BRUNHAM R.C. (1997) DNA vaccination with the major outer-membrane protein gene induces acquired immunity to Chlamydia trachomatis (mouse pneumonitis) infection. J Infect Dis 176, 1035.
26. 26. PEELING R.W., MACLEAN I.W. & BRUNHAM R.C. (1984) In vitro neutralization of Chlamydia trachomatis with monoclonal antibody to an epitope on the major outer membrane protein. Infect Immun 46, 484.
27. 27. YANG X., HAYGLASS K.T. & BRUNMAM R.C. (1996) Genetically determined differences in IL-10 and IFN-γ responses correlate with clearance of Chlamydia trachomatis mouse pneumonitis infection. J Immunol 156, 4338.
28. 28. VANCOTT J.L., STAATS H.F., PASCUAL D.W. et al. (1996) Regulation of mucosal and systemic antibody responses by T helper cell subsets, macrophages, and derived cytokines following oral immunization with live recombinant salmonella. J Immunol 156, 1504.
29. 29. MACLEANT I., PEELING R.W. & BRUNHAM R.C. (1988) Characterization of Chlamydia trachomatis antigens with monoclonal and polyclonal antibodies. Can J Microbiol 34, 141.
30. 30. MOSMANN T.R. (1994) Properties and functions of interleukin 10. Adv Immunol 56, 1.
31. 31. DONNELLY J.J., ULMER J.B., SHIVER J.W. & LIU M.A. (1997) DNA vaccines. In: Annual Review of Immunology (eds Paul W.E., Fathman C.G. & Metzger H.), Vol 15, p. 617. Annual Reviews Inc., California.
32. 32. FU T.-M., ULMER J.B., CAULFIELD M.J. et al. (1997) Priming of cytotoxic T lymphocytes by DNA vaccines: Requirement for professional antigen presenting cells and evidence for antigen transfer from myocytes. Molec Med 3, 362.
33. 33. KLINMAN D.M., YI A.-K., BEAUCAGE S.L., CONOVER J. & KRIEG A.M. (1996) CpG motifs present in bacterial DNA rapidly induce lymphocytes to secrete interleukin 6, inlerleukin 12, and interferon γ. Proc Natl Acad Sci USA 93, 2879.
34. 34. KRIEG A.M., YI A.-K., MATSON S. et al. (1995) CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374, 546.
35. 35. SATO Y., ROMAN M., TIGHE H. et al. (1996) Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science 273, 352.
36. 36. SCHWARTZ D.A., QUINN T.J., THORNE P.S., SAYEED S., YI A.-K. & KRIEG A.M. (1997) CpG motifs in bacterial DNA cause inflammation in the lower respiratory tract. J Clin Invest 100, 68.
37. 37. WATKINS N.G.W.J., HADLOW A.B. & MOOS & CALDWELL H.D. (1986). Ocular delayed hypersensitivity: a pathogenetic mechanism of chlamyial conjuctivitis in guinea pigs. Proc Natl Acad Sci USA 83, 7480.
38. 38. TAYLOR H.R., JOHNSON S.L., SCHACHTER J., CALDWELL H.D. & PRENDERGAST R.A. (1987). Pathogenesis of trachoma: the stimulus for inflammation. J Immunol 138, 3023.